| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.087 | 0.008 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |